261 related articles for article (PubMed ID: 37162589)
21. The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability.
Ganguly S; Naik D; Muskara A; Mian OY
Endocrinology; 2021 Jan; 162(1):. PubMed ID: 33260197
[TBL] [Abstract][Full Text] [Related]
22. Current status of estrogen and progesterone receptors in breast cancer.
McGuire WL; Horwitz KB; Pearson OH; Segaloff A
Cancer; 1977 Jun; 39(6 Suppl):2934-47. PubMed ID: 326386
[TBL] [Abstract][Full Text] [Related]
23. Editorial: Hormone receptors and breast cancer.
Br Med J; 1976 Jul; 2(6027):67-8. PubMed ID: 179660
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor: A promising therapeutic target in breast cancer.
Vasiliou SK; Diamandis EP
Crit Rev Clin Lab Sci; 2019 May; 56(3):200-223. PubMed ID: 30821186
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological Modulation of Steroid Activity in Hormone-Dependent Breast and Prostate Cancers: Effect of Some Plant Extract Derivatives.
Bayala B; Zoure AA; Baron S; de Joussineau C; Simpore J; Lobaccaro JA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456259
[No Abstract] [Full Text] [Related]
26. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
27. A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention.
Jordan VC
Cancer Res; 2009 Feb; 69(4):1243-54. PubMed ID: 19208829
[TBL] [Abstract][Full Text] [Related]
28. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer.
Ormandy CJ; Hall RE; Manning DL; Robertson JF; Blamey RW; Kelly PA; Nicholson RI; Sutherland RL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3692-9. PubMed ID: 9360527
[TBL] [Abstract][Full Text] [Related]
29. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.
Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI
Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168
[TBL] [Abstract][Full Text] [Related]
30. Steroid hormone receptors.
Baulieu EE; Atger M; Best-Belpomme M; Corvol P; Courvalin JC; Mester J; Milgrom E; Robel P; Rochefort H; De Catalogne D
Vitam Horm; 1975; 33():649-736. PubMed ID: 180682
[TBL] [Abstract][Full Text] [Related]
31. Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers.
Cheng M; Michalski S; Kommagani R
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154312
[TBL] [Abstract][Full Text] [Related]
32. Androgen, estrogen, and progesterone receptors in normal and aging prostates.
Srinivasan G; Campbell E; Bashirelahi N
Microsc Res Tech; 1995 Mar; 30(4):293-304. PubMed ID: 7541676
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of the expression of estrogen, progesterone, and androgen receptors by sex steroid hormones in the vagina: immunohistochemical studies.
Pessina MA; Hoyt RF; Goldstein I; Traish AM
J Sex Med; 2006 Sep; 3(5):804-814. PubMed ID: 16942525
[TBL] [Abstract][Full Text] [Related]
34. Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer.
Vontela N; Koduri V; Schwartzberg LS; Vidal GA
J Natl Compr Canc Netw; 2017 Mar; 15(3):284-287. PubMed ID: 28275030
[TBL] [Abstract][Full Text] [Related]
35. Sex steroid hormone metabolism and prostate cancer.
Soronen P; Laiti M; Törn S; Härkönen P; Patrikainen L; Li Y; Pulkka A; Kurkela R; Herrala A; Kaija H; Isomaa V; Vihko P
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):281-6. PubMed ID: 15663991
[TBL] [Abstract][Full Text] [Related]
36. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.
Niemeier LA; Dabbs DJ; Beriwal S; Striebel JM; Bhargava R
Mod Pathol; 2010 Feb; 23(2):205-12. PubMed ID: 19898421
[TBL] [Abstract][Full Text] [Related]
37. [Molecular mechanisms involved in hormone resistance of prostate cancer].
Cabrespine A; Guy L; Chollet P; Debiton E; Bay JO
Bull Cancer; 2004 Oct; 91(10):747-57. PubMed ID: 15556875
[TBL] [Abstract][Full Text] [Related]
38. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
39. Impact of estrogens in males and androgens in females.
Hammes SR; Levin ER
J Clin Invest; 2019 May; 129(5):1818-1826. PubMed ID: 31042159
[TBL] [Abstract][Full Text] [Related]
40. Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers.
Purohit A; Foster PA
J Endocrinol; 2012 Feb; 212(2):99-110. PubMed ID: 21859802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
